Trademark Overview
On Monday, July 14, 2025, a trademark application was filed for AYRMID with the United States Patent and Trademark Office. The USPTO has given the AYRMID trademark a serial number of 99283009. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 14, 2025. This trademark is owned by Ayrmid Pharma Ltd. The AYRMID trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological diseases; pharmaceutical preparations used in hematopoietic transplants; allogenic cell therapy preparations; pharmaceutical preparations for use in hematology and in tissue and organ transplantation